Article Versions Notes

Xu M, Huang X, Zheng C, Long J, Dai Q, Chen Y, Lu J, Pan C, Yao S, Li J. Platinum-Resistant Ovarian Cancer Is Vulnerable to the cJUN-XRCC4 Pathway Inhibition. Cancers. 2022; 14(24):6068. https://doi.org/10.3390/cancers14246068

Xu, Manman, Xi Huang, Cuimiao Zheng, Junming Long, Qingyuan Dai, Yangyang Chen, Jingyi Lu, Chaoyun Pan, Shuzhong Yao, and Jie Li. 2022. "Platinum-Resistant Ovarian Cancer Is Vulnerable to the cJUN-XRCC4 Pathway Inhibition" Cancers 14, no. 24: 6068. https://doi.org/10.3390/cancers14246068

Xu, M., Huang, X., Zheng, C., Long, J., Dai, Q., Chen, Y., Lu, J., Pan, C., Yao, S., & Li, J. (2022). Platinum-Resistant Ovarian Cancer Is Vulnerable to the cJUN-XRCC4 Pathway Inhibition. Cancers, 14(24), 6068. https://doi.org/10.3390/cancers14246068